RE:Resmed High flying Resmed down 2% after their third disappointing quarter in a row - but still 300% up since I bought them three years ago.
ok - some tangible differences in the business model versus VMD. But it continues to shock me how unforgiving the market has been to VMD. We beat earnings by 50%
RMD at PE of 84. We are now 27. Mystifying. If I were a manufacturer of CPAP devices I would be very concerned about China. Our niche is not vulnerable at all given its service intensity. Better minds than my own will understand this.